JW Lifescience Corporation (KRX:234080)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,390
0.00 (0.00%)
At close: Jul 4, 2025, 3:30 PM KST

JW Lifescience Revenue

JW Lifescience had revenue of 76.18B KRW in the quarter ending March 31, 2025, with 37.68% growth. This brings the company's revenue in the last twelve months to 243.33B, up 14.67% year-over-year. In the year 2024, JW Lifescience had annual revenue of 222.48B with 7.55% growth.

Revenue (ttm)
243.33B
Revenue Growth
+14.67%
P/S Ratio
0.81
Revenue / Employee
808.40M
Employees
301
Market Cap
197.58B

Revenue Chart

Revenue History

Fiscal Year End Revenue Change Growth
Dec 31, 2024 222.48B 15.62B 7.55%
Dec 31, 2023 206.86B 17.93B 9.49%
Dec 31, 2022 188.93B 19.11B 11.26%
Dec 31, 2021 169.82B -13.70B -7.47%
Dec 31, 2020 183.52B 13.30B 7.81%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,898.69B
Celltrion 3,662.23B
ALTEOGEN 151.65B
Yuhan 2,114.76B
SK Biopharmaceuticals 578.00B
HLB Co., Ltd. 74.64B
PharmaResearch 392.31B
LigaChem Biosciences 146.42B
Revenue Rankings